tadalafil has been researched along with Urinary Incontinence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fuse, M; Kaga, K; Kageyama, S; Sakata, K; Tokunaga, S; Yamanishi, T; Yokoyama, T | 1 |
| Cho, JS; Jeong, HC; Ko, K; Lee, SH; Lee, SK; Lee, WK; Shin, TY; Yang, DY | 1 |
| Atış, G; Canat, L; Çaşkurlu, T; Güner, B; Gürbüz, C | 1 |
| Andrianne, R; Barry, J; Branicka, J; Büttner, H; Chadwick, D; Cuzin, B; Hell-Momeni, K; Henneges, C; Ilo, D; Patel, HR; Shah, N | 1 |
| Hikita, K; Honda, M; Kawamoto, B; Morizane, S; Muraoka, K; Sejima, T; Takenaka, A | 1 |
| Hubanks, JM; Karnes, RJ; Myers, RP; Umbreit, EC | 1 |
4 trial(s) available for tadalafil and Urinary Incontinence
| Article | Year |
|---|---|
A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study).
Topics: Acetanilides; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents | 2020 |
Effect of tadalafil 5 mg on post-micturition dribble in men with lower urinary tract symptoms: a multicentre, double-blind, randomized, placebo-controlled trial.
Topics: Aged; Double-Blind Method; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Prospective Studies; Tadalafil; Treatment Outcome; Urinary Incontinence | 2019 |
Effects of three-times-per-week versus on-demand tadalafil treatment on erectile function and continence recovery following bilateral nerve sparing radical prostatectomy: results of a prospective, randomized, and single-center study.
Topics: Aged; Carbolines; Drug Administration Schedule; Erectile Dysfunction; Humans; Male; Middle Aged; Penile Erection; Phosphodiesterase 5 Inhibitors; Postoperative Complications; Postoperative Period; Preoperative Period; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Recovery of Function; Tadalafil; Treatment Outcome; Urinary Incontinence | 2015 |
Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study.
Topics: Adenocarcinoma; Aged; Double-Blind Method; Humans; Interpersonal Relations; Male; Middle Aged; Patient Satisfaction; Prostatectomy; Prostatic Neoplasms; Quality of Life; Tadalafil; Urinary Incontinence; Vasodilator Agents | 2015 |
2 other study(ies) available for tadalafil and Urinary Incontinence
| Article | Year |
|---|---|
Impact of postoperative phosphodiesterase type 5 inhibitor treatment on lower urinary tract symptoms after robot-assisted radical prostatectomy: a longitudinal study.
Topics: Aged; Humans; Longitudinal Studies; Lower Urinary Tract Symptoms; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Postoperative Care; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Robotic Surgical Procedures; Tadalafil; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2017 |
Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series.
Topics: Adult; Aged; Carbolines; Coitus; Erectile Dysfunction; Humans; Male; Middle Aged; Neoplasm Grading; Phosphodiesterase 5 Inhibitors; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Quality of Life; Surveys and Questionnaires; Tadalafil; Treatment Outcome; Urinary Incontinence | 2012 |